[HTML][HTML] Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter …
C Lyu, Y Zhang, X Liu, J Wu, J Zhang - BMC Infectious Diseases, 2020 - Springer
Background The prevalence of infections due to carbapenem-resistant Acinetobacter
baumannii (CRAB) is on the rise worldwide. Polymyxins are considered as last-resort drugs …
baumannii (CRAB) is on the rise worldwide. Polymyxins are considered as last-resort drugs …
[HTML][HTML] In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream …
Resistance of Acinetobacter baumannii to multiple clinically important antimicrobials has
increased to very high rates in Greece, rendering most of them obsolete. The aim of this …
increased to very high rates in Greece, rendering most of them obsolete. The aim of this …
Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria
A Sempere, B Viñado, I Los-Arcos… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
This is a retrospective single-center study of 24 patients who received ceftazidime-
avibactam plus aztreonam (CZA/ATM) for the treatment of VIM-type-producing Gram …
avibactam plus aztreonam (CZA/ATM) for the treatment of VIM-type-producing Gram …
[HTML][HTML] Molecular mechanisms of colistin resistance in Africa: a systematic review of literature
A Olowo-Okere, A Yacouba - Germs, 2020 - ncbi.nlm.nih.gov
Molecular mechanisms of colistin resistance in Africa: A systematic review of literature - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity
T Yamada, S Fujii, A Shigemi, Y Takesue - Journal of Infection and …, 2021 - Elsevier
Introduction Antimicrobial resistance is one of the biggest threats to public health systems
worldwide, and aminoglycosides are key drugs for treating drug-resistant infections …
worldwide, and aminoglycosides are key drugs for treating drug-resistant infections …
In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany
M Kresken, M Korte-Berwanger, SG Gatermann… - International journal of …, 2020 - Elsevier
Abstract Objectives: Cefiderocol (CID), also known as S-649266, a novel siderophore
cephalosporin, possesses potent activity against multidrug-resistant aerobic Gram-negative …
cephalosporin, possesses potent activity against multidrug-resistant aerobic Gram-negative …
[HTML][HTML] Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli
S Mancini, M Marchesi, F Imkamp, K Wagner… - …, 2019 - thelancet.com
Background Interpretative reading of antimicrobial susceptibility test (AST) results allows
inferring biochemical resistance mechanisms from resistance phenotypes. For …
inferring biochemical resistance mechanisms from resistance phenotypes. For …
Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia
ED Ibáñez-Prada, IG Bustos… - Microbiology …, 2024 - Am Soc Microbiol
In this study, the genetic differences and clinical impact of the carbapenemase-encoding
genes among the community and healthcare-acquired infections were assessed. This …
genes among the community and healthcare-acquired infections were assessed. This …
Occurrence of blaKPC gene in clinical isolates of Pseudomonas aeruginosa from Brazil
JL da Costa Lima, RM Ximenes… - ABCS Health …, 2022 - portalnepas.org.br
Pseudomonas aeruginosa is one of the main microorganisms causing healthcare-related
infections. The rise of carbapenem-resistant P. aeruginosa (CRPA) strains has become a …
infections. The rise of carbapenem-resistant P. aeruginosa (CRPA) strains has become a …
[HTML][HTML] Understanding resistance in Pseudomonas
Pseudomonas aeruginosa (PA) is the most common multi-drug resistance (MDR) pathogen
in hospitalized patients, increases duration of hospitalization, and, despite the appropriate …
in hospitalized patients, increases duration of hospitalization, and, despite the appropriate …